These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3902615)

  • 1. Fluorescence of damaged myocardium in endomyocardial biopsy specimens for the evaluation of cardiac transplantation.
    Graham AR; Paplanus SH
    Hum Pathol; 1985 Nov; 16(11):1110-4. PubMed ID: 3902615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis.
    Puig M; Ballester M; Matías-Guiu X; Bordes R; Carrió I; Kolodgie FD; Pons C; García A; Aymat MR; Marrugat J; Brossa V; Campreciós M; Padró JM; Caralps JM; Virmani R; Prat J; Narula J
    J Nucl Cardiol; 2000; 7(2):132-9. PubMed ID: 10796002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of fluorescence microscopy for the identification of necrotic myocardium.
    Siegel RJ; Fishbein MC
    Hum Pathol; 1982 Dec; 13(12):1091-4. PubMed ID: 7173851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endomyocardial biopsy.
    Laser JA; Fowles RE; Mason JW
    Cardiovasc Clin; 1985; 15(1):141-63. PubMed ID: 3916087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinicopathological endomyocardial biopsy analysis in cardiac transplant recipients due to end-stage heart failure].
    Li L; Zhao H; Wang HY; Lü FY; Liu L; Wang QZ; Si WX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):819-21. PubMed ID: 17217692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of cardiac transplantation--the initial experience.
    Chopra P; Joshi A; Talwar KK; Airan B; Srivastava S; Venugopal P
    Natl Med J India; 1997; 10(6):264-9. PubMed ID: 9481095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creatine kinase MB isoforms: a potential predictor of acute cardiac allograft rejection.
    Anderson JR; Hossein-Nia M; Brown PA; Corbishley C; Murday AJ; Holt DW
    J Heart Lung Transplant; 1995; 14(4):666-70. PubMed ID: 7578173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endomyocardial biopsy in the evaluation of conditions leading to cardiac transplantation and in the evaluation of cardiac allograft rejection.
    McAllister HA
    Tex Heart Inst J; 1995; 22(1):53-66. PubMed ID: 7787471
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging.
    Ballester M; Bordes R; Tazelaar HD; Carrió I; Marrugat J; Narula J; Billingham ME
    J Am Coll Cardiol; 1998 May; 31(6):1357-61. PubMed ID: 9581733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
    White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endomyocardial biopsy in rejection surveillance after heart transplantation in neonates and children.
    Zales VR; Crawford S; Backer CL; Pahl E; Webb CL; Lynch P; Mavroudis C; Benson DW
    J Am Coll Cardiol; 1994 Mar; 23(3):766-71. PubMed ID: 8113563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endomyocardial biopsy: its history, techniques and current indications.
    Melvin KR; Mason JW
    Can Med Assoc J; 1982 Jun; 126(12):1381-6. PubMed ID: 7044509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum and diagnosis of myocardial rejection.
    Tazelaar HD
    Cardiol Clin; 1990 Feb; 8(1):119-39. PubMed ID: 2407354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expectations and limitations of endomyocardial biopsy.
    Mills AS; Hastillo A; Thompson JA; Hess ML
    Can J Cardiol; 1985; 1(6):358-62. PubMed ID: 3915878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine C4d immunohistochemistry in cardiac allografts: Long-term outcomes.
    Husain AN; Mirza KM; Fedson SE
    J Heart Lung Transplant; 2017 Dec; 36(12):1329-1335. PubMed ID: 28988608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of transplanted heart acute rejection on the basis of endomyocardial biopsy morphologic examination].
    Shumakov VI; Mogilevskiĭ GM; Chestukhin VV; Riavoshtanova EI
    Arkh Patol; 1991; 53(3):11-6. PubMed ID: 1854268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocardial infiltrates in the transplanted heart: clinical significance emerging from the analysis of 5026 endomyocardial biopsy specimens.
    Costanzo-Nordin MR; Winters GL; Fisher SG; O'Sullivan J; Heroux AL; Kao W; Mullen GM; Johnson MR
    J Heart Lung Transplant; 1993; 12(5):741-7. PubMed ID: 8241211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum creatine kinase kinetics after endomyocardial biopsy in cardiac transplant patients.
    Malinowski TR; Wellford AL; Khan N; Rubal BJ
    Mil Med; 1997 Jan; 162(1):51-4. PubMed ID: 9002704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of routine endomyocardial biopsy to monitor late rejection after heart transplantation.
    Spratt P; Sivathasan C; Macdonald P; Keogh A; Chang V
    J Heart Lung Transplant; 1991; 10(6):912-4. PubMed ID: 1756155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.